Position in INSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,349,360
-$1,457,800 QoQ
Shares Held
31,414
+6.9% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#242
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp holds $49,706,140 across 8 Biotechnology names. INSM ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,144 | $18,947,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,583 | $9,716,623 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
19,895 | $5,988,991 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
24,256 | $4,542,663 | |
| 5 | RPRX |
Royalty Pharma plc
|
61,648 | $3,456,603 | |
| 6 | INSM |
INSMED Inc
This page
|
31,414 | $3,349,360 | |
| 7 | INCY |
Incyte Corp
|
25,394 | $2,878,663 | |
| 8 | LEGN |
Legend Biotech Corp
|
28,600 | $825,968 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,349,360 | 31,414 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,807,160 | 29,398 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,527,718 | 37,507 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||